International Psoriasis Council

Advancing Knowledge. Improving Care.

Natalia

Merino

,

MD

Dermatologist
Hospital Nacional Edgardo Rebagliati
Lima
,
Peru
2022 Fellow
IPC Jr. Councilor
Dr. Natalia Merino is a dermatologist at Edgardo Rebagliati Martins National Hospital in Lima, Peru, where she also completed her dermatology fellowship. She is a team member managing the country’s largest cohort of psoriasis patients receiving biologic therapies. Her work is centered on clinical patient care, teaching, and research in psoriasis and oncodermatology, with a special interest in disease management and associated comorbidities of psoriasis.

Dr. Merino completed the IPC International Fellowship in 2022 under the mentorship of IPC Board Member Dr. Claudia de la Cruz in Santiago, Chile.
Last Updated:
07/04/2025

Areas of Interest

Systemic Management of Psoriasis; Comorbidity Management and Adverse Effects; Patient quality of life

IPC Committees / Groups

Latin America Working Group, Regional Development Task Force

Languages Spoken

English, Spanish

Involvement with Other Organization(s)

Dr. Merino collaborates with Asociación Peruana de Psoriasis (APAPSO), the largest psoriasis patient association in Peru, providing educational lectures and supporting public health campaigns to improve disease awareness and patient care.

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026